Therapy With Mesenchymal Stem Cells in Parkinson Disease: History and Perspectives
Conclusions:
The results of MSC therapy in animal models and some clinical trials suggest that such cellular therapy may slow the progression of PD and promote neuroregeneration. However, further research is needed to address the limitations of an eventual clinical application.
Source: The Neurologist - Category: Neurology Tags: Review Article Source Type: research
More News: Brain | Clinical Trials | Neurology | Parkinson's Disease | Stem Cell Therapy | Stem Cells | Study